Sydney Eye Hospital

Sydney 2000

1 studies enrolling now · 5 studies all time

What they study most

Macular Telangiectasia Type 2 (MacTel), Non-arteritic Ischemic Optic Neuropathy, Optic Disk Drusen, Thyroid Eye Disease

Studies at this site

• Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
• A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) — Completed
• A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease — Stopped early
• A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE ) — Completed
• NA-AION Risk Factors: New Perspectives — Completed